Publications
IOIBD Publications committee
Members
Gerassimos Mantzaris, Jim Lewis, Anne Griffiths, Jurgen Schoelmerich, Gil Kaplan, Corey Siegel (Chair)
+ Ad hoc members to help with higher expected volume or specific expertise
Overall Strategy
To have a consistent review process for all material/abstracts/publications that would like to be associated with IOIBD.
Specific approach for manuscripts arising from IOIBD collaborative projects
- Any IOIBD member who conceives an idea to develop material/abstract/manuscript that they want associated with IOIBD should send a brief proposal (1/2 page maximum) to the Chair of the Executive Committee for approval before they develop a draft of their work
- The manuscript ownership will always lie with the authors
- Authorship will be determined by the lead and senior author
- To be included as an author, all must meet standard authorship criteria
- The manuscript author list will include “on behalf of the International Organization for the Study of Inflammatory Bowel Diseases” after the senior author, and/or the manuscript title will include IOIBD.
- When made possible by the journal, IOIBD members who contributed to the project but do not qualify as authors (e.g., expert panels) will be listed in the authorship banner (listed in PubMed)
- It is OK to include non-IOIBD co-authors, but in general the majority of authors should be IOIBD members
- In the acknowledgments, there will be a notation for authors who are members of IOIBD
- The review committee will review the material/abstract/manuscript (guidance below) and make a recommendation to the IOIBD executive committee for final approval
- Once approved by the executive committee, the authors will submit abstracts/manuscripts on their own
Guidance for reviewers of material/abstract/manuscript arising from IOIBD collaborative projects
- Is it clear and without any glaring issues?
- Feel free to comment on content and make recommendations to the authors to improve the manuscript. However, detailed editing as you would as a co-author or journal reviewer is not required.
- Is it appropriate to represent IOIBD and have the IOIBD “stamp of approval”?
- Send comments to the Chair of the Publications Committee who will send collective comments to the authors and make a recommendation to the executive committee
For individual research projects that have been funded by IOIBD but not an IOIBD collaborative project, these will not be reviewed by the committee but the authors will acknowledge funding in the manuscript.
IOIBD latest publications
Remzi FH, Panis Y, Spinelli A, Kotze PG, Mantzaris G, Söderholm JD, d’Hoore A, Bemelman WA, Yamamoto T, Pemberton JH, Tiret E, Øresland T, Fleshner P.Dis Colon Rectum. 2020 Jul;63(7):870-873. doi: 10.1097/DCR.0000000000001718.
Rubin DT, Abreu MT, Rai V, Siegel CA; International Organization for the Study of Inflammatory Bowel Disease.Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6.PMID: 32272113 Free PMC article. No abstract available.
Abreu MT, Sandborn WJ; IOIBD Defining Endpoints and Biomarkers in Inflammatory Bowel Disease Writing Group.Gastroenterology. 2020 Sep 19:S0016-5085(20)35168-4. doi: 10.1053/j.gastro.2020.07.064. Online ahead of print.PMID: 32961246\
https://pubmed.ncbi.nlm.nih.gov/32959882/
Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
Dotan I, Panaccione R, Kaplan GG, O’Morain C, Lindsay JO, Abreu MT; IOIBD.J Crohns Colitis. 2020 Sep 22:jjaa147. doi: 10.1093/ecco-jcc/jjaa147. Online ahead of print.PMID: 32959882
Allez M, Fleshner P, Gearry R, Lakatos PL, Rubin DT; IOIBD.J Crohns Colitis. 2020 Jul 29:jjaa150. doi: 10.1093/ecco-jcc/jjaa150. Online ahead of print.PMID: 32722757
Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Boneh RS, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer S, Hammami MB, Garces LC, Rogler G, Koutroubakis IE, Ananthakrishnan AN, McKeever L, Lewis JD.Clin Gastroenterol Hepatol. 2020 May;18(6):1381-1392. doi: 10.1016/j.cgh.2020.01.046. Epub 2020 Feb 15.
IOIBD supported papers
D’Haens G, Rieder F, Feagan BG, Higgins PDR, Panes J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; IOIBD Fibrosis Working Group.
Gastroenterology. 2019 Jun 26. pii: S0016-5085(19)41035-4. doi: 10.1053/j.gastro.2019.05.072.
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease
Authors: Heike Schmitt,1 Ulrike Billmeier,1 Walburga Dieterich,1 Timo Rath,1 Sophia Sonnewald,2
Stephen Reid,2 Simon Hirschmann,1 Kai Hildner,1 Maximilian J Waldner,1
Jonas Mudter,3 Arndt Hartmann,4 Robert Grützmann,5 Clemens Neufert,1
Tino Münster,6 Markus F Neurath,1 Raja Atreya1
Published: GUT Journal, 16 June 2018
Download the PDF of this publication:
Expansion of IL-23 receptor bearing TNFR2+ T cells (IOIBD supported paper)
Stable incidence of collagenous collitis and lymphocytic colitis in Orebro, Sweden, 1999-2008: a continuous epidemiological study.
Authors: Wickbom, A., Bohr, J., Udumyan, R., Nylin, N., Tysk, C.
Publication: Inflammatory Bowel Disease 2013: 19:2387-2393
Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn’s disease recurrence: interim results from a randomized, multicenter trial
AUTHORS (LAST NAME, FIRST NAME): Ferrante, Marc1; Papamichael, Konstantinos4; Duricova, Dana.5; D’Haens, Geert R.2, 3; Vermeire, Severine1; Archavlis, Emmanuel J.4; Rutgeerts, Paul J.1; Bortlik, Martin5; Mantzaris, Gerassimos J.4; Van Assche, Gert A.1
Download the PDF of this publication here >>
Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris G, Kornbluth A, Rachmilewitz D, Lichtiger S, D’Haens GR, van der Woude, CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts P and IOIBD members
Validation of Endoscopic Activity Scores in Patients with Crohn’s Disease Based on a Post-Hoc Analysis of Data from SONIC
under revision for publication in Gastroenterology
Wickbom A, Bohr J, Eriksson S, Udumyan R, Nyhlin N, Tysk C.
Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiological study.
Submitted
Shaw S, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. American Journal of Gastroenterology 2010; 105: 2687-2692.
Shaw S, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn’s disease and ulcerative colitis. American Journal of Gastroenterology 2011; 106:2133-42
Kaul A, Huftless S, Liu L, Bayless T, Marohn MR, Li X.
Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis.
Inflamm Bowel Dis 2012 Oct;18(10):1872-84.
Laharie D et al.
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.
Shaw S, Blanchard JF, Bernstein CN. Association between early childhood otitis media and pediatric inflammatory bowel disease: an exploratory population-based analysis.
Journal of Pediatrics 2013; 162: 510-4.
IOIBD papers (task forces)
Role of biomarkers in the study and management of inflammatory bowel disease: a “non systematic” review
https://www-ncbi-nlm-nih-gov.eresources.mssm.edu/pubmed/25222663
Sachar DB; Biomarkers Task Force of the IOIBD.
Inflamm Bowel Dis. 2014 Dec;20(12):2511-8.
Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
Hospitalisations and surgery in Crohn’s disease.
Gut. 2012 Apr; 61(4):622-9.
Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV Jr, Tysk C, O’Morain C, Moum B, Colombel JF , Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
Geographic variability of environmental risk factors in inflammatory bowel disease.
Gut. 2013 Apr; 62(4):630-49.
Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease
Inflamm Bowel Dis. In press.
D’Haens G, Feagan B, Colombel JF, Sandborn WJ, Reinisch W, Rutgeerts P, Carbonnel F, Mary JY, Danese S, Fedorak RN, Hanauer S, Lémann M; International Organization for Inflammatory Bowel Diseases IOIBD and the Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organization ECCO.
Challenges to the design, execution and analysis of randomized controlled trials for Inflammatory Bowel Diseases
Gastroenterology. 2012;143:1461-9.
2012
Hospitalisations and surgery in Crohn’s disease
Date: 1 March 2012 – Published by group.bmj.com
IBD Full Papers
Stocchi L, Pemberton JH. Pouch and pouchitis. Gastroenterol Clin North Am. 2001 Mar; 30(1):223-41. PMID:11394032.
Cima RR, Pemberton JH. Surgical Management of Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2001 Jun; 4(3):215-225. PMID:11469979.
Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, Zinsmeister AR, Norton ID, Boardman LA, Devine RM, Wolff BG, Young-Fadok TM, Diehl NN, Pemberton JH, Sandborn WJ. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001 Nov; 121(5):1064-72. PMID:11677197.
Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med. 2001 Nov 20; 135(10):906-18. PMID:11712881.
Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis. 2002 Sep; 8(5):311-6. PMID:12479645.
Solem CA, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Sandborn WJ. Fistulas to the urinary system in Crohn’s disease: Clinical features and outcomes. Am J Gastroenterol. 2002 Sep; 97(9):2300-5. PMID:12358248.
Colombel JF, Ricart E, Loftus EV, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ. Management of Crohn’s disease of the ileoanal pouch with infliximab. Am J Gastroenterol. 2003 Oct; 98(10):2239-44. PMID:14572574.
Cima RR, Pemberton JH. Surgical indications and procedures in ulcerative colitis. Curr Treat Options Gastroenterol. 2004; 7(3):181-90. PMID:15149580.
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR The effect of ageing on function, quality of life in ileal pouch patients. A single cohort experience of 409 patients with chronic ulcerative colitis. Annals of Surgery 2004 Oct; 240(4):615-23.
Carne PW, Pemberton JH. Technical aspects of ileoanal pouch surgery. Clin Colon Rectal Surg. 2004 Feb; 17(1):35-41. PMID:20011283. PMCID:2780069. DOI:10.1055/s-2004-823069.
Cima RR, Pemberton JH. Protagonist: Early surgical intervention in ulcerative colitis. Gut. 2004 Feb; 53(2):306-7. PMID:14724168. PMCID:1774919.
Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004 May; 99(5):878-83. PMID:15128354.
Larson DW, Pemberton JH. Current concepts and controversies in surgery for IBD. Gastroenterology. 2004 May; 126(6):1611-9. PMID:15168371.
Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, Dozois RR. Pregnancy and delivery before and after real pouch-anal anastomosis for inflammatory bowel disease: Immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004 Jul; 47(7):1127-35. PMID:15164253.
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis. Ann Surg. 2004 Oct; 240(4):615-21; discussion 621-3. PMID:15383789. PMCID:1356463.
Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis. Arch Surg. 2005 Mar; 140(3):300-10. PMID:15781797.
Chapman JR, Larson DW, Wolff BG, Dozois EJ, Cima RR, Pemberton JH, Crownhart BS, Larson DR. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch Surg. 2005 Jun; 140(6):534-9; discussion 539-40. PMID:15967900.
Larson DW, Cima RR, Dozois EJ, Davies M, Piotrowicz K, Barnes SA, Wolff B, Pemberton J. Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience. Ann Surg. 2006 May; 243(5):667-70; discussion 670-2. PMID:16633002. PMCID:1570559. DOI:10.1097/01.sla.0000216762.83407.d2.
Taylor WE, Wolff BG, Pemberton JH, Yaszemski MJ. Sacral osteomyelitis after ileal pouch-anal anastomosis: report of four cases. Dis Colon Rectum. 2006 Jun; 49(6):913-8. PMID:16741645. DOI:10.1007/s10350-006-0524-3.
Cima R, Pemberton JH. How a hand-assist can help in lap colectomy. Contemporary Surgery. 2007 Jan; 63(1):19-23.
Hochman DJ, Pemberton JH. Hand-assisted laparoscopic total proctocolectomy and ileal pouch-anal anastomosis after liver transplant for primary sclerosing cholangitis. Surg Laparosc Endosc Percutan Tech. 2007 Feb; 17(1):56-7. PMID:17318059. DOI:10.1097/01.sle.0000213764.48052.f1.
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007 Mar; 94(3):333-40. PMID:17225210.
Selvasekar CR, Cima RR, Larson DW, Dozois EJ, Harrington JR, Harmsen WS, Loftus EV Jr, Sandborn WJ, Wolff BG, Pemberton JH. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg. 2007 May; 204(5):956-62; discussion 962-3. PMID:17481518.
Cima RR, Anderson KJ, Larson DW, Dozois EJ, Hassan I, Sandborn WJ, Loftus EV, Pemberton JH. Internet use by patients in an inflammatory bowel disease specialty clinic. Inflamm Bowel Dis. 2007 Oct; 13(10):1266-70. PMID:17567877. DOI:10.1002/ibd.20198.
Hassan I, You YN, Cima RR, Larson DW, Dozois EJ, Barnes SA, Pemberton JH. Hand-assisted versus laparoscopic-assisted colorectal surgery: Practice patterns and clinical outcomes in a minimally-invasive colorectal practice. Surg Endosc. 2008 Mar; 22(3):739-43. PMID:17704883. DOI:10.1007/s00464-007-9477-4.
Larson DW, Davies MM, Dozois EJ, Cima RR, Piotrowicz K, Anderson K, Barnes SA, Harmsen WS, Young-Fadok TM, Wolff BG, Pemberton JH. Sexual function, body image, and quality of life after laparoscopic and open ileal pouch-anal anastomosis. Dis Colon Rectum. 2008 Apr; 51(4):392-6. Epub 2008 Jan 24. PMID:18213489. DOI:10.1007/s10350-007-9180-5.
Benavente-Chenhalls L, Mathis KL, Dozois EJ, Cima RR, Pemberton JH, Larson DW. Laparoscopic ileal pouch-anal anastomosis in patients with chronic ulcerative colitis and primary sclerosing cholangitis: a case-matched study. Dis Colon Rectum. 2008 May; 51(5):549-53. Epub 2008 Mar 04. PMID:18317838. DOI:10.1007/s10350-008-9250-3.
Cima RR, Pattana-arun J, Larson DW, Dozois EJ, Wolff BG, Pemberton JH. Experience with 969 minimal access colectomies: the role of hand-assisted laparoscopy in expanding minimally invasive surgery for complex colectomies. J Am Coll Surg. 2008 May; 206(5):946-50; discussion 950-2. Epub 2008 Mar 03. PMID:18471731. DOI:10.1016/j.jamcollsurg.2007.12.021.
Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmiento JM, Wolff BG, Heimbach JK, Pemberton JH. Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg. 2008 Jul; 95(7):882-6. PMID:18496886. DOI:10.1002/bjs.6210.
Holubar SD, Cima RR, Pemberton JH. Does infliximab increase complications after surgery for inflammatory bowel disease? F1000 Med Rep. 2009; 1. Epub 2009 Jan 21. PMID:20948772. PMCID:2920702. DOI:10.3410/M1-10.
Holubar SD, Larson DW, Dozois EJ, Pattana-Arun J, Pemberton JH, Cima RR. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum. 2009 Feb; 52(2):187-92. PMID:19279410. DOI:10.1007/DCR.0b013e31819a5cc1.
Taner T, Cima RR, Larson DW, Dozois EJ, Pemberton JH, Wolff BG. The use of human acellular dermal matrix for parastomal hernia repair in patients with inflammatory bowel disease: a novel technique to repair fascial defects. Dis Colon Rectum. 2009 Feb; 52(2):349-54. PMID:19279435. DOI:10.1007/DCR.0b013e31819a3e69.
Mathis KL, Dozois EJ, Larson DW, Cima RR, Wolff BG, Pemberton JH. Outcomes in patients with ulcerative colitis undergoing partial or complete reconstructive surgery for failing ileal pouch-anal anastomosis. Ann Surg. 2009 Mar; 249(3):409-13. PMID:19247027. DOI:10.1097/SLA.0b013e31819a697b.
Taner T, Cima RR, Larson DW, Dozois EJ, Pemberton JH, Wolff BG. Surgical treatment of complex enterocutaneous fistulas in IBD patients using human acellular dermal matrix. Inflamm Bowel Dis. 2009 Aug; 15(8):1208-12. PMID:19170192. DOI:10.1002/ibd.20882.
Holubar SD, Privitera A, Cima RR, Dozois EJ, Pemberton JH, Larson DW. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis. 2009 Sep; 15(9):1337-42. PMID:19266572. DOI:10.1002/ibd.20914.
Holubar SD, Long KH, Loftus EV Jr, Wolff BG, Pemberton JH, Cima RR. Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota. Dis Colon Rectum. 2009 Nov; 52(11):1815-23. PMID:19966626. PMCID:2791910. NIHMS:148475. DOI:10.1007/DCR.0b013e3181b327a6.
Holubar SD, Dozois EJ, Privitera A, Cima RR, Pemberton JH, Young-Fadok T, Larson DW. Laparoscopic surgery for recurrent ileocolic Crohn’s disease. Inflamm Bowel Dis. 2010 Aug; 16(8):1382-6. PMID:20027655. DOI:10.1002/ibd.21186.
Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2010 Oct 25. [Epub ahead of print] PMID:20976714. DOI:10.1002/ibd.21504.
Holubar SD, Dozois EJ, Privitera A, Pemberton JH, Cima RR, Larson DW. Minimally invasive colectomy for Crohn’s colitis: a single institution experience. Inflamm Bowel Dis. 2010 Nov; 16(11):1940-6. PMID:20848480. DOI:10.1002/ibd.21265.
Nasir BS, Dozois EJ, Cima RR, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn’s disease. J Gastrointest Surg. 2010 Dec; 14(12):1859-65; discussion 1865-6. Epub 2010 Sep 25. PMID:20872084. DOI:10.1007/s11605-010-1341-5.
Holubar SD, Pendlimari R, Loftus EV, Moriarty JP, Larson D, O’Byrne M, Pemberton JH, Cima RP. Drivers of cost after surgical and medical therapy for chronic ulcerative colitis: a nested case-cohort study in Olmsted County, Minnesota. Inflamm Bowel Dis. 2011; 17(7):1557-63.
Mathis KL, Cima RR, Pemberton JH. New developments in colorectal surgery. Curr Opin Gastroenterol. 2011 Jan; 27(1):48-53. PMID:20975554. DOI:10.1097/MOG.0b013e328340b842.
Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2011 Jul; 17(7):1610-9. Epub 2010 Oct 25. PMID:21674718. DOI:10.1002/ibd.21504.
Cima RR, Pendlimari R, Holubar SD, Pattana-Arun J, Larson DW, Dozois EJ, Wolff BG, Pemberton JH. Utility and short-term outcomes of hand-assisted laparoscopic colorectal surgery: a single-institution experience in 1103 patients. Dis Colon Rectum. 2011 Sep; 54(9):1076-81. PMID:21825886. DOI:10.1007/DCR.0b013e3182155904.
Iqbal CW, Cima RR, Pemberton JH. Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations. J Gastrointest Surg. 2011 Nov; 15(11):2016-22. Epub 2011 Jul 01. PMID:21720925. DOI:10.1007/s11605-011-1611-x.
IBD Book chapters
Horgan AF, Sandborn WJ, Pemberton JH. What are the causes and treatment of ileoanal pouch dysfunction? In: Jewell DP, Mortensen NJ, Warren BF. Challenges in Inflammatory Bowel Disease. Oxford, UK: Blackwell Science; 2001. p. 179-89. (Book chapter)
Pemberton JH. Long-term results with ileoanal pouch. In: Bayless TM, Hanauer SB, editors. Advanced Therapy of Inflammatory Bowel Disease. Hamilton: B. C. Decker; 2001. p. 203-7. (Book chapter)
Pemberton JH, Phillips SF. Ileostomy and its alternatives. Chapter 105, 2068-2079 in: Sleisenger & Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Dr. M. Feldman, Dr. L. Friedman, Dr. M. Sleisenger, Editors. Vol. 2. Seventh Edition. Saunders, Elsevier Science, 2002. (Book chapter)
Pemberton JH, Phillips SF. Ileostomy and its alternatives. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran’s gastrointestinal and liver disease : pathophysiology, diagnosis, management. 7th Edition. Volume 2. Philadelphia: Saunders; 2002. p. 2068-79. (Book chapter)
Pemberton JH. Clinical features of posterior pelvic floor. In: Pemberton J, Swash M, Henry MM, editors. The Pelvic Floor: Its Function and Disorders. London: W. B. Saunders; 2002. p. 167-71. (Book chapter)
Sagar PM, Pemberton JH. Surgery for inflammatory bowel disease: chronic ulcerative colitis. In: Zuidema GD, Yeo CJ, editors. Shackelford’s Surgery of the Alimentary Tract. 5th Edition. Volume 4. Philadelphia: W. B. Saunders Co.; 2002. p. 84-103. (Book chapter)
Sagar PM, Pemberton JH. Surgical treatment of ulcerative colitis. Inflammatory Bowel Diseases. Edited by Satsangi, Sutherland, Colombel, Fiocchi, Lofberg, Pemberton, Rutgeerts. Churchill Livingstone, 2003;491-511. (Book chapter)
Sagar PM, Pemberton JH. Surgical treatment of chronic ulcerative colitis. In: Satsangi J, Sutherland LR, editors. Inflammatory bowel diseases. Churchill Livingstone; 2003. p. 491-511. (Book chapter)
Cima RR, Pemberton JH, Young-Fadok TM. Procedures for Ulcerative Colitis (Chapter 27). In: ACS Surgery Online. WebMD Inc.; 2004. (Book chapter)
Cima RR, Pemberton JH. Surgical management of ulcerative colitis. In: Sartor RB, Sandborn WJ, editors. Kirsner’s inflammatory bowel disease. 6th Edition. Edinburgh: Saunders; 2004. p. 602-13. (Book chapter)
Cima RR, Pemberton JH. Ulcerative colitis and Crohn’s colitis: colon, rectum and anus. In: Lillemoe, KD and Schulick RD (eds). New York, NY; 2004. (Book chapter)
Taylor WE, Pemberton JH. Stoma physiology. In: Cataldo PA, MacKeigan JM, editors. Intestinal stomas: principles, techniques, and management. 2nd, rev. and expanded Edition. New York: Marcel Dekker; 2004. p. 39-55. (Book chapter)
Cima RR, Young-Fadok T, Pemberton JH. Procedures for ulcerative colitis. In: Souba WW, et al, editors. ACS surgery: principles & practice 2005. New York: WebMD Professional Pub.; 2005. p. 674-84. (Book chapter)
Larson DW, Pemberton JH. Perianal disease in inflammatory bowel diseases. In: Bayless TM, Diehl AM, editors. Advanced therapy in gastroenterology and liver disease. 5th Edition. Hamilton: B. C. Decker; 2005. p. 476-84. (Book chapter)
Cima RR, Pemberton JH. Ileostomy, colostomy, and pouches. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th Edition. Volume 2. Philadelphia: Saunders Elsevier; 2006. p. 2549-61. (Book chapter)
Horgan AF, Sandborn WJ, Pemberton JH. What are the causes and treatment of ileoanal pouch dysfunction? In: Jewell DP, Mortensen NJ, Steinhart AH, Pemberton JH, Warren BF. Challenges in Inflammatory Bowel Disease. Blackwell Publishers Ltd; 2006. p. 167-178. (Book chapter)
Cima RR, Young-Fadok T, Pemberton JH. Procedures for ulcerative colitis. In: Souba WW, Fink MP, Jurkovich GJ, Kaiser LR, Pearce WH, Pemberton JH, Soper NJ, editors. ACS surgery: principles & practice. 6th Edition. New York: WebMD Professional Pub.; 2007. p. 910-20. (Book chapter)
Sagar PM, Pemberton JH. Surgery for inflammatory bowel disease: chronic ulcerative colitis. In: Yeo CJ, editor. Shackelford’s surgery of the alimentary tract. 6th ed. Vol. 2. Philadelphia: Saunders; 2007. p. 2101-26. (Book chapter)
Cima RR, Pemberton JH. Strictureplasty in Crohn’s disease. In: In: Cameron JL, editor.. Current surgical therapy. 9th ed. Philadelphia: Mosby Elsevier; 2008. p. 128-32. (Book chapter)
Holubar SD, Cima RR, Pemberton JH. Infliximab is a relative indication for staged surgery in inflammatory bowel disease. In: ACS Surgery Principles & Practice BC Decker; May 2009. (Book chapter)
Cima RR, Pemberton JH. Ileostomy, colostomy, and pouches. In: Feldman M; Friedman LS; Brandt LJ editor. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 9th Edition. Philadelphia: Saunders/Elsevier; 2010. p. 2015-25. (Book chapter)
Cima RR, Pemberton JH. Long-term results with ileal pouch-anal anastomosis. In: Bayless TM, Hanauer SB. Advanced Therapy in Inflammatory Bowel Disease. 3rd ed. June 2011. (Book chapter)
2011
Serum Anti-glycan Antibody Biomarkers for Inflammatory Bowel Disease Diagnosis and Progression: A Systematic Review and Meta-analysis Amit Kaul, MD,* Susan Hutfless, PhD,† Ling Liu, MD,† Theodore M. Bayless, MD,† Michael R. Marohn, DO, FACS,* and Xuhang Li, PhD† Date: 7 December 2011
Shaw S, Blanchard JF, Bernstein CN.
Association between the use of antibiotics and new diagnoses of Crohn’s disease and ulcerative colitis. American Journal of Gastroenterology 2011; 106:2133-42.
2010
Studies as a result of IOBID Grants
Shaw SY Blanchard JF , Bernstein CN . Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010 Dec;105(12):2687-92. Epub 2010 Oct 12.
Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D’Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010–Inflammatory Bowel Disease Task Force meeting.Inflamm Bowel Dis. 2011 Feb;17(2):639-44.
J . S. Barrett, R. B. Gearry, J. G. Muir, P. M. Irving, R. Rose, O. Rosella, M. L. Haines, S. J . Shepherd & P. R. Gibson.Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31, 874–882.
Lodolce JP, Kolodziej LK, Rhee L, Kariuki SN, Franek BS, McGreal NM, Logsdon MF, Bartulis SJ, Perera MA, Ellis NA, Adams EJ, Hanauer SB, Jolly M, Niewold TB, and Boone DL (2010). African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. Journal of Immunology. 2010 Jun 15;184(12):7001-9
Peyrin-Biroulet L, Cieza A, Sandborn WJ, Kostanjsek N, Kamm MA, Hibi T, Lémann M, Stucki G, Colombel JF.Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis.2010 Jan;16(1):15-22.
Oral Presentations
Pekow, J., Joseph, L.J., Venu, N., Huang, Y., Gometz, E., Dougherty, U., Liu, Q., Nathanson, J., Cohen, G., Levy, S.E., Hart, J., Yan, B., Noffsinger, A.E., Hanauer, S.B., Hurst, R.D., Fichera, A., Bissonnette, M. Ulcerative Colitis Gene Signature Distinguishes Patients Harboring Remote Dysplasia.Gastroenterology138: S-46, 2010 (Oral presentation)
2009
Goel A, Mittal A, Evstatiev R, Nemeth M, Kruis W, Stoltes M, Boland R & Gasche C. In vivo effects of mesalazine or E.coli Nissle 1917 on microsatellite instability in ulcerative colitis.Aliment Pharmacol Ther2009; 30, 634–642
Geert R. D’Haens, MD,* Richard Fedorak, MD, Marc Lemann, MD, Brian G. Feagan, MD, Michael A. Kamm, MD, Jacques Cosnes, MD, Paul J. Rutgeerts, MD, Philippe Marteau, MD, Simon Travis, MD, Jurgen Scholmerich, MD, Steven Hanauer, MD, William J. Sandborn, MD and the IOIBD Membership
Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn’s Disease 2009
Inflamm Bowel Dis 2009;000:000–000 2009 Endpoints.pdf
Studies as a result of IOIBD Grant
Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK.Associations between common variants in the MDR 1 (ABCB 1) gene and ulcerative colitis among North Indians.Pharmacogenet Genomics 2009 Jan;19(1):77-85.
2008
Geboes K, Colombel JF, Greenstein A, Jewell D, Sandborn W, Vatn M, Warren B, Riddell RH. Indeterminate colitis : A review of the concept – What’s in a name? Inflamm Bowel Dis 2008; 14: 860-7
Karel Geboes, MD, Jean-Frederic Colombel, MD, Adrian Greenstein, MD, Derek P. Jewell, MD, William J. Sandborn, MD, Morten H. Vatn, MD, Bryan Warren, MD, Robert H. Riddell, MD,
and The Pathology Task Force of the International Organization of Inflammatory Bowel Diseases (IOIBD; K.G., D.P.J, B.W., R.H.R.)
Indeterminate Colitis: A Review of the Concept — What’s in a Name?
Inflamm Bowel Dis 2008;14:850 – 857 Indeterminate.pdf
Studies as a result of IOIBD Grants
Hafner, S., A. Timmer, H. Herfarth, G. Rogler, J. Schölmerich, A. Schäffler, B. Ehrenstein, W. Jilg, C. Ott, U. Strauch, F. Obermeier:
The role of domestic hygiene in inflammatory bowel disease: Hepatitis A and worm infestations.
Eur. J. Gastroenterol. Hepatol.20, 561-566 (2008)
Ott, C., F. Obermeier, S. Thieler, D. Kemptner, A. Bauer, U. Strauch, J. Schölmerich, G. Rogler, A. Timmer:
The incidence of inflammatory bowel disease in a rural region of southern Germany – a prospective population based study.
Eur. J. Gastroenterol. Hepatol. 20, 917-923 (2008)
2007
Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR. A pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007;13:1522-8.
Geert d’Haens, William J. Sandborn, Brian G. Feagan, Karel Geboes, Stephen B. Hanauer, E. Jan Irvine, Marc Lémann, Philippe Marteau, Paul Rutgeerts, Jurgen Schölmerich, and Lloyd R. Sutherland
A Review of Activity Indices and Efficacy End Points for Clinical Trials of
Medical Therapy in Adults With Ulcerative Colitis
Gastroenterology 2007;132:763–786
2007 A review of activity indices .pdf
Catherine Croagh, MB, BS, Susan J. Shepherd, BApplSci, Melissa Berryman, BApplSci, Jane G. Muir, PhD, and
Peter R. Gibson, MD
Pilot Study on the Effect of Reducing Dietary FODMAP
Intake on Bowel Function in Patients without a Colon
Inflamm Bowel Dis 2007;13:1522–1528
Pouch.pdf
Halfvarson J, Jess T, Bodin L, Järnerot G, Orholm M, Munkholm P, Binder V, Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease.Inflammatory Bowel Disease 2007;13:1536-1544.
D’Haens, G., W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, E.J. Irvine, M. Lémann, P. Marteau, P. Rutgeerts, J. Schölmerich, L.R. Sutherland:
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 132, 763-786 (2007)
Juyal G, Amre D, Midha V, Sood A, Seidman E, Thelma BK.Evidence of allelic heterogeneity for associations between NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment Pharmacol Ther. 2007;26(10):1325-32
Contact
IOIBD Scientific Secretariat
Call Us
+31 35 5426745
Email Us
info@ioibd.org
Our Location
3742 CN Baarn
The Netherlands